SCHEMBL30762595

SCHEMBL30762595

CC(=O)c1cc(C)cc2c(N3CCOCC3)cc(N3CCCCC3)nc12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 9/20 0.46
▸ ATRIP Q8WXE1 6/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ KDM4E B2RXH2 4/20 0.43
▸ HIF1A Q16665 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PIK3C2B O00750 1/20 0.40
▸ GBA1 P04062 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762505 0.80 L3MBTL1 (0.50) ATRATRIPALDH1A1KDM4EHIF1A
SCHEMBL30762525 0.79 ATR (0.47) ATRATRIPALDH1A1KDM4EGAA
SCHEMBL30762409 0.77 ALDH1A1 (0.54) ALDH1A1KDM4ETSHRGBA1GAA
SCHEMBL30762483 0.76 SHMT2 (0.49) ALDH1A1KDM4EHIF1APIK3C2BPKM
SCHEMBL30762588 0.76 KDM4E (0.53) ALDH1A1KDM4ETSHRGBA1PKM
SCHEMBL30784185 0.74 AKT1 (0.41) ALDH1A1KDM4EHIF1APIK3C2BMAPT
SCHEMBL23299953 0.73 KMT2A (0.56) ALDH1A1KDM4ETSHRNPC1GAA
SCHEMBL30784025 0.73 KMT2A (0.45) ALDH1A1KDM4ETSHRPIK3C2BGAA
SCHEMBL30783705 0.73 AKT1 (0.43) ALDH1A1KDM4EHIF1APIK3C2BGLA
SCHEMBL30783809 0.72 SMN1; SMN2 (0.48) ALDH1A1KDM4ETSHRGBA1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback